Biological

CHO Cells clinical trials

studies test it: 15
open now: 1
in phase 3: 1
first study started: 2020

Keep track of what changes. Save the CHO Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Recombinant novel coronavirus vaccine (CHO cells): 5
Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells): 3
Recombinant novel coronavirus protein vaccine (CHO cells): 3
Low dose Recombinant Herpes Zoster Vaccine (CHO cells): 2
High dose Recombinant Herpes Zoster Vaccine (CHO cells): 2

Studies by the year they started

15 studies that test it; most in 2022 (4)

Studies that test CHO Cells, by start year
Year	Studies
2020	3
2021	3
2022	4
2023	4
2024	1

By phase

A phase 1/2 study counts in both.

Phase 1: 9
Phase 2: 7
Phase 3: 1
No phase: 3

What it is tested for

Each study’s main condition, where its own words name it.

COVID-19: 3
Herpes Zoster: 2

Who runs them

Industry 15 · Other 0

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (12) · MAXVAX Biotechnology Limited Liability Company (3)

Often tested with

Tested in the same studies.

CHO cell (3) · Adjuvant (1)

Studies

Open first, then newest update. How each study uses CHO Cells is read from its arms, and is right about nine times in ten.